@article{SchofferSchueleinArandetal.2016,
  author    = {Schoffer, Olaf and Sch{\"u}lein, Stefanie and Arand, Gerlinde and Arnholdt, Hans and Baaske, Dieter and Bargou, Ralf C. and Becker, Nikolaus and Beckmann, Matthias W. and Bodack, Yves and B{\"o}hme, Beatrix and Bozkurt, Tayfun and Breitsprecher, Regine and Buchali, Andre and Burger, Elke and Burger, Ulrike and Dommisch, Klaus and Elsner, Gudrun and Fernschild, Karin and Flintzer, Ulrike and Funke, Uwe and Gerken, Michael and G{\"o}bel, Hubert and Grobe, Norbert and Gumpp, Vera and Heinzerling, Lucie and Kempfer, Lana Raffaela and Kiani, Alexander and Klinkhammer-Schalke, Monika and Kl{\"o}cking, Sabine and Kreibich, Ute and Knabner, Katrin and Kuhn, Peter and Lutze, Stine and M{\"a}der, Uwe and Maisel, Tanja and Maschke, Jan and Middeke, Martin and Neubauer, Andreas and Niedostatek, Antje and Opazo-Saez, Anabelle and Peters, Christoph and Schell, Beatrice and Schenkirsch, Gerhard and Schmalenberg, Harald and Schmidt, Peter and Schneider, Constanze and Schubotz, Birgit and Seide, Anika and Strecker, Paul and Taubenheim, Sabine and Wackes, Matthias and Weiß, Steffen and Welke, Claudia and Werner, Carmen and Wittekind, Christian and Wulff, J{\"o}rg and Zettl, Heike and Klug, Stefanie J.},
  title     = {Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011},
  series = {BMC Cancer},
  volume    = {16},
  journal   = {BMC Cancer},
  number    = {936},
  doi       = {10.1186/s12885-016-2963-0},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-164544},
  year      = {2016},
  abstract  = {Background Over the past two decades, there has been a rising trend in malignant melanoma incidence worldwide. In 2008, Germany introduced a nationwide skin cancer screening program starting at age 35. The aims of this study were to analyse the distribution of malignant melanoma tumour stages over time, as well as demographic and regional differences in stage distribution and survival of melanoma patients. Methods Pooled data from 61 895 malignant melanoma patients diagnosed between 2002 and 2011 and documented in 28 German population-based and hospital-based clinical cancer registries were analysed using descriptive methods, joinpoint regression, logistic regression and relative survival. Results The number of annually documented cases increased by 53.2\% between 2002 (N = 4 779) and 2011 (N = 7 320). There was a statistically significant continuous positive trend in the proportion of stage UICC I cases diagnosed between 2002 and 2011, compared to a negative trend for stage UICC II. No trends were found for stages UICC III and IV respectively. Age (OR 0.97, 95\% CI 0.97-0.97), sex (OR 1.18, 95\% CI 1.11-1.25), date of diagnosis (OR 1.05, 95\% CI 1.04-1.06), 'diagnosis during screening' (OR 3.24, 95\% CI 2.50-4.19) and place of residence (OR 1.23, 95\% CI 1.16-1.30) had a statistically significant influence on the tumour stage at diagnosis. The overall 5-year relative survival for invasive cases was 83.4\% (95\% CI 82.8-83.9\%). Conclusions No distinct changes in the distribution of malignant melanoma tumour stages among those aged 35 and older were seen that could be directly attributed to the introduction of skin cancer screening in 2008. "},
  language  = {en}
}
@article{TonyBurmesterSchulzeKoopsetal.2011,
  author    = {Tony, Hans-Peter and Burmester, Gerd and Schulze-Koops, Hendrik and Grunke, Mathias and Henes, Joerg and K{\"o}tter, Ina and Haas, Judith and Unger, Leonore and Lovric, Svjetlana and Haubitz, Marion and Fischer-Betz, Rebecca and Chehab, Gamal and Rubbert-Roth, Andrea and Specker, Christof and Weinerth, Jutta and Holle, Julia and M{\"u}ller-Ladner, Ulf and K{\"o}nig, Ramona and Fiehn, Christoph and Burgwinkel, Philip and Budde, Klemens and S{\"o}rensen, Helmut and Meurer, Michael and Aringer, Martin and Kieseier, Bernd and Erfurt-Berge, Cornelia and Sticherling, Michael and Veelken, Roland and Ziemann, Ulf and Strutz, Frank and von Wussow, Praxis and Meier, Florian MP and Hunzelmann, Nico and Schmidt, Enno and Bergner, Raoul and Schwarting, Andreas and Eming, R{\"u}diger and Schwarz-Eywill, Michael and Wassenberg, Siegfried and Fleck, Martin and Metzler, Claudia and Zettl, Uwe and Westphal, Jens and Heitmann, Stefan and Herzog, Anna L. and Wiendl, Heinz and Jakob, Waltraud and Schmidt, Elvira and Freivogel, Klaus and D{\"o}rner, Thomas and Hertl, Michael and Stadler, Rudolf},
  title     = {Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)},
  series = {Arthritis Research \& Therapy},
  volume    = {13},
  journal   = {Arthritis Research \& Therapy},
  number    = {R75},
  doi       = {10.1186/ar3337},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-142856},
  pages     = {1-14},
  year      = {2011},
  abstract  = {Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma in a real-life clinical setting. Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune Diseases. The main outcome measures were safety and clinical response, as judged at the discretion of the investigators. Results: A total of 370 patients (299 patient-years) with various autoimmune diseases (23.0\% with systemic lupus erythematosus, 15.7\% antineutrophil cytoplasmic antibody-associated granulomatous vasculitides, 15.1\% multiple sclerosis and 10.0\% pemphigus) from 42 centres received a mean dose of 2,440 mg of rituximab over a median (range) of 194 (180 to 1,407) days. The overall rate of serious infections was 5.3 per 100 patient-years during rituximab therapy. Opportunistic infections were infrequent across the whole study population, and mostly occurred in patients with systemic lupus erythematosus. There were 11 deaths (3.0\% of patients) after rituximab treatment (mean 11.6 months after first infusion, range 0.8 to 31.3 months), with most of the deaths caused by infections. Overall (n = 293), 13.3\% of patients showed no response, 45.1\% showed a partial response and 41.6\% showed a complete response. Responses were also reflected by reduced use of glucocorticoids and various immunosuppressives during rituximab therapy and follow-up compared with before rituximab. Rituximab generally had a positive effect on patient well-being (physician's visual analogue scale; mean improvement from baseline of 12.1 mm)},
  language  = {en}
}
@unpublished{BraunschweigKrummenacherLichtenbergetal.2016,
  author    = {Braunschweig, Holger and Krummenacher, Ivo and Lichtenberg, Crispin and Mattock, James and Sch{\"a}fer, Marius and Schmidt, Uwe and Schneider, Christoph and Steffenhagen, Thomas and Ullrich, Stefan and Vargas, Alfredo},
  title     = {Dibora[2]ferrocenophane: A Carbene-Stabilized Diborene in a Strained cis-Configuration},
  series = {Angewandte Chemie, International Edition},
  journal   = {Angewandte Chemie, International Edition},
  doi       = {10.1002/anie.201609601},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-141981},
  pages     = {9},
  year      = {2016},
  abstract  = {Unsaturated bridges that link the two cyclopentadienyl ligands together in strained ansa metallocenes are rare and limited to carbon-carbon double bonds. The synthesis and isolation of a strained ferrocenophane containing an unsaturated two-boron bridge, isoelectronic with a C=C double bond, was achieved by reduction of a carbene-stabilized 1,1'-bis(dihaloboryl)ferrocene. A combination of spectroscopic and electrochemical measurements as well as density functional theory (DFT) calculations was used to assess the influence of the unprecedented strained cis configuration on the optical and electrochemical properties of the carbene-stabilized diborene unit. Initial reactivity studies show that the dibora[2]ferrocenophane is prone to boron-boron double bond cleavage reactions.},
  subject      = {Metallocene},
  language  = {en}
}
@unpublished{ArrowsmithDoemlingSchmidtetal.2019,
  author    = {Arrowsmith, Merle and D{\"o}mling, Michael and Schmidt, Uwe and Werner, Luis and Castro, Abril C. and Jim{\´e}nez-Halla, J. Oscar C. and M{\"u}ssig, Jonas and Prieschl, Dominic and Braunschweig, Holger},
  title     = {Spontaneous trans-Selective Transfer Hydrogenation of Apolar B=B Double Bonds},
  series = {Angewandte Chemie, International Edition},
  journal   = {Angewandte Chemie, International Edition},
  doi       = {10.1002/anie.201902656},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-184874},
  year      = {2019},
  abstract  = {The transfer hydrogenation of NHC-supported diborenes with dimethylamine borane proceeds with high selectivity for the trans-1,2-dihydrodiboranes(6). DFT calculations suggest a stepwise proton-first-hydride-second reaction mechanism via an intermediate μ-hydrodiboronium dimethylaminoborate ion pair.},
  language  = {en}
}
@article{MuellerThomasRudeliusRondaketal.2014,
  author    = {M{\"u}ller-Thomas, Catharina and Rudelius, Martina and Rondak, Ina-Christine and Haferlach, Torsten and Schanz, Julie and Huberle, Christina and Schmidt, Burkard and Blaser, Rainer and Kremer, Marcus and Peschel, Christian and Germing, Ulrich and Platzbecker, Uwe and Goetze, Katharina},
  title     = {Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia},
  series = {HAEMATOLOGICA},
  volume    = {99},
  journal   = {HAEMATOLOGICA},
  number    = {10},
  issn      = {1592-8721},
  doi       = {10.3324/haematol.2014.104760},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-115313},
  pages     = {E179-E181},
  year      = {2014},
  abstract  = {No abstract available.},
  language  = {en}
}
@unpublished{SchmidtFantuzziArrowsmithetal.2020,
  author    = {Schmidt, Uwe and Fantuzzi, Felipe and Arrowsmith, Merle and Hermann, Alexander and Prieschl, Dominic and Rempel, Anna and Engels, Bernd and Braunschweig, Holger},
  title     = {Tuneable reduction of cymantrenylboranes to diborenes or borylene-derived boratafulvenes},
  series = {Chemical Communications},
  journal   = {Chemical Communications},
  doi       = {10.1039/D0CC06398C},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-222149},
  year      = {2020},
  abstract  = {Whereas the reduction of N-heterocyclic carbene (NHC)-stabilised cymantrenyldibromoboranes, (NHC)BBr\(_2\)Cym, in benzene results in formation of the corresponding diborenes (NHC)\(_2\)B\(_2\)Cym\(_2\), a change of solvent to THF yields a borylene of the form (NHC)\(_2\)BCym, stabilised through its boratafulvene resonance form.},
  language  = {en}
}
@phdthesis{Schmidt2022,
  author    = {Schmidt, Uwe},
  title     = {Sandwich- und Halbsandwich-substituierte Diborene - Synthese, Eigenschaften und Reaktivit{\"a}t},
  doi       = {10.25972/OPUS-23460},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-234601},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2022},
  abstract  = {Innerhalb der vorliegenden Arbeit ist es gelungen, durch das Einf{\"u}hren von Cymantrenylresten neue Diborene darzustellen, welche Halbsandwich-Substituenten tragen und somit das Substitutionsmuster von basenstabilisierten Diborenen um eine weitere Verbindungsklasse zu erweitern. Neben Cymantrenylresten gelang es auch, Ferrocenylreste als weitere Substituenten in entsprechende Diborensysteme einzuf{\"u}hren. {\"U}ber die Darstellung neuer Diborensysteme hinaus, waren Reaktivit{\"a}tsstudien am Diboraferrocenophan 29 ebenso ein wesentlicher Bestandteil der vorliegenden Arbeit. Es konnte gezeigt werden, dass 29 mit kleinen Lewis-Basen, Element-Wasserstoff-Verbindungen und Hydrierungsreagenzien zur Reaktion gebracht werden kann.},
  subject      = {Diborene},
  language  = {de}
}
@article{SchmidtEbnerRosenetal.2020,
  author    = {Schmidt, Stefanie and Ebner, Friederike and Rosen, Kerstin and Kniemeyer, Olaf and Brakhage, Axel A. and L{\"o}ffler, J{\"u}rgen and Seif, Michelle and Springer, Jan and Schlosser, Josephine and Scharek-Tedin, Lydia and Scheffold, Alexander and Bacher, Petra and K{\"u}hl, Anja A. and R{\"o}sler, Uwe and Hartmann, Susanne},
  title     = {The domestic pig as human-relevant large animal model to study adaptive antifungal immune responses against airborne Aspergillus fumigatus},
  series = {European Journal of Immunology},
  volume    = {50},
  journal   = {European Journal of Immunology},
  number    = {11},
  doi       = {10.1002/eji.201948524},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-216085},
  pages     = {1712 -- 1728},
  year      = {2020},
  abstract  = {Pulmonary mucosal immune response is critical for preventing opportunistic Aspergillus fumigatus infections. Although fungus-specific CD4\(^{+}\) T cells in blood are described to reflect the actual host-pathogen interaction status, little is known about Aspergillus-specific pulmonary T-cell responses. Here, we exploit the domestic pig as human-relevant large animal model and introduce antigen-specific T-cell enrichment in pigs to address Aspergillus-specific T cells in the lung compared to peripheral blood. In healthy, environmentally Aspergillus-exposed pigs, the fungus-specific T cells are detectable in blood in similar frequencies as observed in healthy humans and exhibit a Th1 phenotype. Exposing pigs to 10\(^{6}\) cfu/m\(^{3}\) conidia induces a long-lasting accumulation of Aspergillus-specific Th1 cells locally in the lung and also systemically. Temporary immunosuppression during Aspergillus-exposure showed a drastic reduction in the lung-infiltrating antifungal T-cell responses more than 2 weeks after abrogation of the suppressive treatment. This was reflected in blood, but to a much lesser extent. In conclusion, by using the human-relevant large animal model the pig, this study highlights that the blood clearly reflects the mucosal fungal-specific T-cell reactivity in environmentally exposed as well as experimentally exposed healthy pigs. But, immunosuppression significantly impacts the mucosal site in contrast to the initial systemic immune response.},
  language  = {en}
}
@article{SchmidtWernerArrowsmithetal.2020,
  author    = {Schmidt, Uwe and Werner, Luis and Arrowsmith, Merle and Deissenberger, Andrea and Hermann, Alexander and Hofmann, Alexander and Ullrich, Stefan and Mattock, James D. and Vargas, Alfredo and Braunschweig, Holger},
  title     = {Trans-selektive Dihydroborierung eines cis-Diborens durch Insertion: Synthese eines linearen sp\(^3\)-sp\(^2\)-sp\(^3\)-Triborans und anschließende Kationisierung},
  series = {Angewandte Chemie},
  volume    = {132},
  journal   = {Angewandte Chemie},
  number    = {1},
  doi       = {10.1002/ange.201911645},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-219713},
  pages     = {333-337},
  year      = {2020},
  abstract  = {Die Reaktion zwischen Aryl- und Amino(dihydro)boranen und Dibora[2]ferrocenophan 1 f{\"u}hrt zur Bildung von 1,3-trans-Dihydrotriboranen durch formale Hydrierung und Insertion eines Borylens in die B=B Doppelbindung. Die Aryltriboran-Derivate unterliegen einer reversiblen Photoisomerisierung zugunsten eines cis-1,2-μ-H-3-Hydrotriborans, w{\"a}hrend eine Hydridabstraktion zu kationischen Triboranen f{\"u}hrt, welche die ersten doppelt basenstabilisierten B\(_3\)H\(_4\)\(^+\)-Analoga darstellen.},
  language  = {de}
}
@article{SchmidtWernerArrowsmithetal.2020,
  author    = {Schmidt, Uwe and Werner, Luis and Arrowsmith, Merle and Deissenberger, Andrea and Hermann, Alexander and Hofmann, Alexander and Ullrich, Stefan and Mattock, James D. and Vargas, Alfredo and Braunschweig, Holger},
  title     = {trans-Selective Insertional Dihydroboration of a cis-Diborene: Synthesis of Linear sp\(^3\)-sp\(^2\)-sp\(^3\)-Triboranes and Subsequent Cationization},
  series = {Angewandte Chemie International Edition},
  volume    = {59},
  journal   = {Angewandte Chemie International Edition},
  number    = {1},
  doi       = {10.1002/anie.201911645},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-208090},
  pages     = {325-329},
  year      = {2020},
  abstract  = {The reaction of aryl- and amino(dihydro)boranes with dibora[2]ferrocenophane 1 leads to the formation 1,3-trans -dihydrotriboranes by formal hydrogenation and insertion of a borylene unit into the B=B bond. The aryltriborane derivatives undergo reversible photoisomerization to the cis -1,2-μ-H-3-hydrotriboranes, while hydride abstraction affords cationic triboranes, which represent the first doubly base-stabilized B3H4\(^+\) analogues.},
  language  = {en}
}